The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America

John S Bradley, Carrie L Byington, Samir S Shah, Brian Alverson, Edward R Carter, Christopher Harrison, Sheldon L Kaplan, Sharon E Mace, George H McCracken Jr, Matthew R Moore, Shawn D St Peter, Jana A Stockwell, Jack T Swanson, Pediatric Infectious Diseases Society and the Infectious Diseases Society of America, John S Bradley, Carrie L Byington, Samir S Shah, Brian Alverson, Edward R Carter, Christopher Harrison, Sheldon L Kaplan, Sharon E Mace, George H McCracken Jr, Matthew R Moore, Shawn D St Peter, Jana A Stockwell, Jack T Swanson, Pediatric Infectious Diseases Society and the Infectious Diseases Society of America

Abstract

Evidenced-based guidelines for management of infants and children with community-acquired pneumonia (CAP) were prepared by an expert panel comprising clinicians and investigators representing community pediatrics, public health, and the pediatric specialties of critical care, emergency medicine, hospital medicine, infectious diseases, pulmonology, and surgery. These guidelines are intended for use by primary care and subspecialty providers responsible for the management of otherwise healthy infants and children with CAP in both outpatient and inpatient settings. Site-of-care management, diagnosis, antimicrobial and adjunctive surgical therapy, and prevention are discussed. Areas that warrant future investigations are also highlighted.

Figures

Figure 1.
Figure 1.
Management of pneumonia with parapneumonic effusion; abx, antibiotics; CT, computed tomography; dx, diagnosis; IV, intravenous; US, ultrasound; VATS, video-assisted thoracoscopic surgery.

References

    1. Dean NC, Bateman KA, Donnelly SM, et al. Improved clinical outcomes with utilization of a community-acquired pneumonia guideline. Chest. 2006;130:794–9.
    1. McCabe C, Kirchner C, Zhang H, et al. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med. 2009;169:1525–31.
    1. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–6.
    1. Wardlaw T, Salama P, Johansson EW, et al. Pneumonia: the leading killer of children. Lancet. 2006;368:1048–50.
    1. World Health Organization. Pneumonia. Fact sheet No. 331. 2009. Available at: . Accessed 7 September 2010.
    1. McCracken GH., Jr Etiology and treatment of pneumonia. Pediatr Infect Dis J. 2000;19:373–7.
    1. McIntosh K. Community-acquired pneumonia in children. N Engl J Med. 2002;346:429–37.
    1. Grijalva CG, Poehling KA, Nuorti JP, et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics. 2006;118:865–73.
    1. Lee GE, Lorch SA, Sheffler-Collins S, et al. National hospitalization trends for pediatric pneumonia and associated complications. Pediatrics. 2010;126:204–13.
    1. Heron M, Hoyert DL, Murphy SL, et al. Deaths: final data for 2006. Natl Vital Stat Rep. 2009;57:1–134.
    1. British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in childhood. Thorax. 2002;57:i1–24.
    1. Lee PI, Chiu CH, Chen PY, et al. Guidelines for the management of community-acquired pneumonia in children. Acta Paediatr Taiwan. 2007;48:167–80.
    1. US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry. Community-acquired bacterial pneumonia: developing drugs for treatment. 2009. Available at: . Accessed 7 September 2010.
    1. Drummond P, Clark J, Wheeler J, et al. Community acquired pneumonia: a prospective UK study. Arch Dis Child. 2000;83:408–12.
    1. Heiskanen-Kosma T, Korppi M, Jokinen C, et al. Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J. 1998;17:986–91.
    1. Juven T, Mertsola J, Waris M, et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J. 2000;19:293–8.
    1. Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2004;113:701–7.
    1. Wubbel L, Muniz L, Ahmed A, et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J. 1999;18:98–104.
    1. Bonzel L, Tenenbaum T, Schroten H, et al. Frequent detection of viral coinfection in children hospitalized with acute respiratory tract infection using a real-time polymerase chain reaction. Pediatr Infect Dis J. 2008;27:589–94.
    1. Hamano-Hasegawa K, Morozumi M, Nakayama E, et al. Comprehensive detection of causative pathogens using real-time PCR to diagnose pediatric community-acquired pneumonia. J Infect Chemother. 2008;14:424–32.
    1. Techasaensiri C, Messina AF, Katz K, et al. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas. Pediatr Infect Dis J. 2010;29:294–300.
    1. Brieu N, Guyon G, Rodiere M, et al. Human bocavirus infection in children with respiratory tract disease. Pediatr Infect Dis J. 2008;27:969–73.
    1. Dawood FS, Fiore A, Kamimoto L, et al. Influenza-associated pneumonia in children hospitalized with laboratory-confirmed influenza, 2003–2008. Pediatr Infect Dis J. 2010;29:585–90.
    1. Ng V, Tang P, Jamieson F, et al. Laboratory-based evaluation of legionellosis epidemiology in Ontario, Canada, 1978 to 2006. BMC Infect Dis. 2009;9:68.
    1. Tuberculosis. Red Book. 2009;2009:680–701.
    1. Field MJ, Lohr KN. Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice Guidelines. Clinical practice guidelines: directions for a new program. Washington, DC: National Academies Press; 1990. pp. 8–0.
    1. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–72.
    1. Mace S. Pneumonia. In: Ahrens WR, Schafermeyer RW, editors. Pediatric emergency medicine. Vol. Chapter 142. New York: McGraw-Hill, 2010.
    1. Jadavji T, Law B, Lebel MH, et al. A practical guide for the diagnosis and treatment of pediatric pneumonia. CMAJ. 1997;156:S703–11.
    1. Sandora TJ, Harper MB. Pneumonia in hospitalized children. Pediatr Clin North Am. 2005;52:1059–81. viii.
    1. Kirelik S. Pneumonia. In: Marx JA, Hockenberger R, Walls RM, et al., editors. Rosen's emergency medicine concepts and clinical practice. Philadelphia, PA: Mosby Elsevier; 2008. pp. 2554–64.
    1. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243–50.
    1. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58:377–82.
    1. Capelastegui A, Espana PP, Quintana JM, et al. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J. 2006;27:151–7.
    1. Aujesky D, Auble TE, Yealy DM, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med. 2005;118:384–92.
    1. Fine MJ, Stone RA, Singer DE, et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med. 1999;159:970–80.
    1. Mortensen EM, Coley CM, Singer DE, et al. Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med. 2002;162:1059–64.
    1. Auble TE, Yealy DM, Fine MJ. Assessing prognosis and selecting an initial site of care for adults with community-acquired pneumonia. Infect Dis Clin North Am. 1998;12:741–59. x.
    1. Nazarian DJ, Eddy OL, Lukens TW, et al. Clinical policy: critical issues in the management of adult patients presenting to the emergency department with community-acquired pneumonia. Ann Emerg Med. 2009;54:704–31.
    1. Ruttimann UE, Pollack MM. Objective assessment of changing mortality risks in pediatric intensive care unit patients. Crit Care Med. 1991;19:474–83.
    1. Peters MJ, Tasker RC, Kiff KM, et al. Acute hypoxemic respiratory failure in children: case mix and the utility of respiratory severity indices. Intensive Care Med. 1998;24:699–705.
    1. Delport SD, Brisley T. Aetiology and outcome of severe community-acquired pneumonia in children admitted to a paediatric intensive care unit. S Afr Med J. 2002;92:907–11.
    1. Gillet Y, Vanhems P, Lina G, et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis. 2007;45:315–21.
    1. Mayordomo-Colunga J, Medina A, Rey C, et al. Predictive factors of non invasive ventilation failure in critically ill children: a prospective epidemiological study. Intensive Care Med. 2009;35:527–36.
    1. Fu LY, Ruthazer R, Wilson I, et al. Brief hospitalization and pulse oximetry for predicting amoxicillin treatment failure in children with severe pneumonia. Pediatrics. 2006;118:e1822–30.
    1. Niederman MS, Bass JB, Jr., Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis. 1993;148:1418–26.
    1. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med. 1995;333:1618–24.
    1. Fine MJ, Hanusa BH, Lave JR, et al. Comparison of a disease-specific and a generic severity of illness measure for patients with community-acquired pneumonia. J Gen Intern Med. 1995;10:359–68.
    1. Brown L, Dannenberg B. Pulse oximetry in discharge decision-making: a survey of emergency physicians. CJEM. 2002;4:388–93.
    1. Lozano JM, Steinhoff M, Ruiz JG, et al. Clinical predictors of acute radiological pneumonia and hypoxaemia at high altitude. Arch Dis Child. 1994;71:323–7.
    1. Margolis PA, Ferkol TW, Marsocci S, et al. Accuracy of the clinical examination in detecting hypoxemia in infants with respiratory illness. J Pediatr. 1994;124:552–60.
    1. Demers AM, Morency P, Mberyo-Yaah F, et al. Risk factors for mortality among children hospitalized because of acute respiratory infections in Bangui, Central African Republic. Pediatr Infect Dis J. 2000;19:424–32.
    1. Ayieko P, English M. In children aged 2-59 months with pneumonia, which clinical signs best predict hypoxaemia? J Trop Pediatr. 2006;52:307–10.
    1. Mamtani M, Patel A, Hibberd PL, et al. A clinical tool to predict failed response to therapy in children with severe pneumonia. Pediatr Pulmonol. 2009;44:379–86.
    1. Smyth A, Carty H, Hart CA. Clinical predictors of hypoxaemia in children with pneumonia. Ann Trop Paediatr. 1998;18:31–40.
    1. Shah S, Bachur R, Kim D, et al. Lack of predictive value of tachypnea in the diagnosis of pneumonia in children. Pediatr Infect Dis J. 2010;29:406–9.
    1. Murtagh P, Cerqueiro C, Halac A, et al. Acute lower respiratory infection in Argentinian children: a 40 month clinical and epidemiological study. Pediatr Pulmonol. 1993;16:1–8.
    1. Flores G, Abreu M, Chaisson CE, et al. Keeping children out of hospitals: parents' and physicians' perspectives on how pediatric hospitalizations for ambulatory care-sensitive conditions can be avoided. Pediatrics. 2003;112:1021–30.
    1. Agha MM, Glazier RH, Guttmann A. Relationship between social inequalities and ambulatory care-sensitive hospitalizations persists for up to 9 years among children born in a major Canadian urban center. Ambul Pediatr. 2007;7:258–62.
    1. Castaldo ET, Yang EY. Severe sepsis attributable to community-associated methicillin-resistant Staphylococcus aureus: an emerging fatal problem. Am Surg. 2007;73:684–7. discussion 87–8.
    1. Gonzalez BE, Martinez-Aguilar G, Hulten KG, et al. Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics. 2005;115:642–8.
    1. Tan TQ, Mason EO, Jr., Barson WJ, et al. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcuspneumoniae. Pediatrics. 1998;102:1369–75.
    1. Bender JM, Ampofo K, Gesteland P, et al. Development and validation of a risk score for predicting hospitalization in children with influenza virus infection. Pediatr Emerg Care. 2009;25:369–75.
    1. Louie JK, Schechter R, Honarmand S, et al. Severe pediatric influenza in California, 2003–2005: implications for immunization recommendations. Pediatrics. 2006;117:e610–8.
    1. von Renesse A, Schildgen O, Klinkenberg D, et al. Respiratory syncytial virus infection in children admitted to hospital but ventilated mechanically for other reasons. J Med Virol. 2009;81:160–6.
    1. Graf JM, Montagnino BA, Hueckel R, et al. Pediatric tracheostomies: a recent experience from one academic center. Pediatr Crit Care Med. 2008;9:96–100.
    1. US Bureau of the Census. Statistical abstract of the United States. 127th ed. Washington, DC: US Government Printing Office; 2008. pp. 159–0.
    1. Shann F, Barker J, Poore P. Clinical signs that predict death in children with severe pneumonia. Pediatr Infect Dis J. 1989;8:852–5.
    1. Sebastian R, Skowronski DM, Chong M, et al. Age-related trends in the timeliness and prediction of medical visits, hospitalizations and deaths due to pneumonia and influenza, British Columbia, Canada, 1998–2004. Vaccine. 2008;26:1397–403.
    1. Duncan H, Hutchison J, Parshuram CS. The Pediatric Early Warning System score: a severity of illness score to predict urgent medical need in hospitalized children. J Crit Care. 2006;21:271–8.
    1. Campbell H, Byass P, Lamont AC, et al. Assessment of clinical criteria for identification of severe acute lower respiratory tract infections in children. Lancet. 1989;1:297–9.
    1. Techasaensiri B, Techasaensiri C, Mejias A, et al. Viral coinfections in children with invasive pneumococcal disease. Pediatr Infect Dis J. 2009;29:519–23.
    1. Lynch T, Bialy L, Kellner JD, et al. A systematic review on the diagnosis of pediatric bacterial pneumonia: when gold is bronze. PLoS One. 2010;5:e11989.
    1. Hickey RW, Bowman MJ, Smith GA. Utility of blood cultures in pediatric patients found to have pneumonia in the emergency department. Ann Emerg Med. 1996;27:721–5.
    1. Shah SS, Alpern ER, Zwerling L, et al. Risk of bacteremia in young children with pneumonia treated as outpatients. Arch Pediatr Adolesc Med. 2003;157:389–92.
    1. Claesson BA, Trollfors B, Brolin I, et al. Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens. Pediatr Infect Dis J. 1989;8:856–62.
    1. Tsarouhas N, Shaw KN, Hodinka RL, et al. Effectiveness of intramuscular penicillin versus oral amoxicillin in the early treatment of outpatient pediatric pneumonia. Pediatr Emerg Care. 1998;14:338–41.
    1. Bonadio WA. Bacteremia in febrile children with lobar pneumonia and leukocytosis. Pediatr Emerg Care. 1988;4:241–2.
    1. Black SB, Shinefield HR, Ling S, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J. 2002;21:810–5.
    1. Shah SS, Dugan MH, Bell LM, et al. Blood cultures in the emergency department evaluation of childhood pneumonia. Pediatr Infect Dis J. 2011;30:475–79.
    1. Alpern ER, Alessandrini EA, Bell LM, et al. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. Pediatrics. 2000;106:505–11.
    1. Stoll ML, Rubin LG. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center. Arch Pediatr Adolesc Med. 2004;158:671–5.
    1. Herz AM, Greenhow TL, Alcantara J, et al. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine. Pediatr Infect Dis J. 2006;25:293–300.
    1. Sard B, Bailey MC, Vinci R. An analysis of pediatric blood cultures in the postpneumococcal conjugate vaccine era in a community hospital emergency department. Pediatr Emerg Care. 2006;22:295–300.
    1. Mtunthama N, Gordon SB, Kusimbwe T, et al. Blood culture collection technique and pneumococcal surveillance in Malawi during the four year period 2003–2006: an observational study. BMC Infect Dis. 2008;8:137.
    1. Petti CA, Woods CW, Reller LB. Streptococcus pneumoniae antigen test using positive blood culture bottles as an alternative method to diagnose pneumococcal bacteremia. J Clin Microbiol. 2005;43:2510–2.
    1. Resti M, Micheli A, Moriondo M, et al. Comparison of the effect of antibiotic treatment on the possibility of diagnosing invasive pneumococcal disease by culture or molecular methods: a prospective, observational study of children and adolescents with proven pneumococcal infection. Clin Ther. 2009;31:1266–73.
    1. Sandora TJ, Desai R, Miko BA, et al. Assessing quality indicators for pediatric community-acquired pneumonia. Am J Med Qual. 2009;24:419–27.
    1. Byington CL, Spencer LY, Johnson TA, et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis. 2002;34:434–40.
    1. Freij BJ, Kusmiesz H, Nelson JD, et al. Parapneumonic effusions and empyema in hospitalized children: a retrospective review of 227 cases. Pediatr Infect Dis. 1984;3:578–91.
    1. Hoff SJ, Neblett WW, Edwards KM, et al. Parapneumonic empyema in children: decortication hastens recovery in patients with severe pleural infections. Pediatr Infect Dis J. 1991;10:194–9.
    1. St Peter SD, Tsao K, Spilde TL, et al. Thoracoscopic decortication vs tube thoracostomy with fibrinolysis for empyema in children: a prospective, randomized trial. J Pediatr Surg. 2009;44:106–11. discussion 11.
    1. Buckingham SC, King MD, Miller ML. Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001. Pediatr Infect Dis J. 2003;22:499–504.
    1. Campbell SG, Marrie TJ, Anstey R, et al. The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: a prospective observational study. Chest. 2003;123:1142–50.
    1. Corbo J, Friedman B, Bijur P, et al. Limited usefulness of initial blood cultures in community acquired pneumonia. Emerg Med J. 2004;21:446–8.
    1. Kennedy M, Bates DW, Wright SB, et al. Do emergency department blood cultures change practice in patients with pneumonia? Ann Emerg Med. 2005;46:393–400.
    1. Afshar N, Tabas J, Afshar K, et al. Blood cultures for community-acquired pneumonia: are they worthy of two quality measures? A systematic review. J Hosp Med. 2009;4:112–23.
    1. Centers for Disease Control and Prevention. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children: Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep. 2010;59:258–61.
    1. Centers for Disease Control and Prevention Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine: United States, 2007. MMWR Morb Mortal Wkly Rep. 2010;59:253–7.
    1. Ishida T, Hashimoto T, Arita M, et al. A 3-year prospective study of a urinary antigen-detection test for Streptococcus pneumoniae in community-acquired pneumonia: utility and clinical impact on the reported etiology. J Infect Chemother. 2004;10:359–63.
    1. Roson B, Fernandez-Sabe N, Carratala J, et al. Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia. Clin Infect Dis. 2004;38:222–6.
    1. Neuman MI, Harper MB. Evaluation of a rapid urine antigen assay for the detection of invasive pneumococcal disease in children. Pediatrics. 2003;112:1279–82.
    1. Dowell SF, Garman RL, Liu G, et al. Evaluation of Binax NOW, an assay for the detection of pneumococcal antigen in urine samples, performed among pediatric patients. Clin Infect Dis. 2001;32:824–5.
    1. Esposito S, Bosis S, Colombo R, et al. Evaluation of rapid assay for detection of Streptococcus pneumoniae urinary antigen among infants and young children with possible invasive pneumococcal disease. Pediatr Infect Dis J. 2004;23:365–7.
    1. Charkaluk ML, Kalach N, Mvogo H, et al. Assessment of a rapid urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal infection in children. Diagn Microbiol Infect Dis. 2006;55:89–94.
    1. Bonner AB, Monroe KW, Talley LI, et al. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics. 2003;112:363–7.
    1. Esposito S, Marchisio P, Morelli P, et al. Effect of a rapid influenza diagnosis. Arch Dis Child. 2003;88:525–6.
    1. Iyer SB, Gerber MA, Pomerantz WJ, et al. Effect of point-of-care influenza testing on management of febrile children. Acad Emerg Med. 2006;13:1259–68.
    1. Benito-Fernandez J, Vazquez-Ronco MA, Morteruel-Aizkuren E, et al. Impact of rapid viral testing for influenza A and B viruses on management of febrile infants without signs of focal infection. Pediatr Infect Dis J. 2006;25:1153–7.
    1. Abanses JC, Dowd MD, Simon SD, et al. Impact of rapid influenza testing at triage on management of febrile infants and young children. Pediatr Emerg Care. 2006;22:145–9.
    1. Doan QH, Kissoon N, Dobson S, et al. A randomized, controlled trial of the impact of early and rapid diagnosis of viral infections in children brought to an emergency department with febrile respiratory tract illnesses. J Pediatr. 2009;154:91–5.
    1. Falsey AR, Murata Y, Walsh EE. Impact of rapid diagnosis on management of adults hospitalized with influenza. Arch Intern Med. 2007;167:354–60.
    1. Byington CL, Castillo H, Gerber K, et al. The effect of rapid respiratory viral diagnostic testing on antibiotic use in a children's hospital. Arch Pediatr Adolesc Med. 2002;156:1230–4.
    1. Louie JK, Guevara H, Boston E, et al. Rapid influenza antigen test for diagnosis of pandemic (H1N1) 2009. Emerg Infect Dis. 2010;16:824–6.
    1. Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003–2004. N Engl J Med. 2005;353:2559–67.
    1. Centers for Disease Control and Prevention. Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection: United States, April–August 2009. MMWR Morb Mortal Wkly Rep. 2009;58:941–7.
    1. Levin D, Tribuzio M, Green-Wrzesinki T, et al. Empiric antibiotics are justified for infants with respiratory syncytial virus lower respiratory tract infection presenting with respiratory failure: a prospective study and evidence review. Pediatr Crit Care Med. 2010;11:390–5.
    1. Block S, Hedrick J, Hammerschlag MR, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J. 1995;14:471–7.
    1. Gendrel D. Antibiotic treatment of Mycoplasma pneumoniae infections. Pediatr Pulmonol Suppl. 1997;16:46–7.
    1. Harris JA, Kolokathis A, Campbell M, et al. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr Infect Dis J. 1998;17:865–71.
    1. Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology. 2004;9:109–14.
    1. Glezen WP, Loda FA, Clyde WA, Jr, et al. Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice. J Pediatr. 1971;78:397–406.
    1. Marmion BP. Eaton agent–science and scientific acceptance: a historical commentary. Rev Infect Dis. 1990;12:338–53.
    1. Alexander TS, Gray LD, Kraft JA, et al. Performance of Meridian ImmunoCard Mycoplasma test in a multicenter clinical trial. J Clin Microbiol. 1996;34:1180–3.
    1. Dunn JJ, Malan AK, Evans J, et al. Rapid detection of Mycoplasma pneumoniae IgM antibodies in pediatric patients using ImmunoCard Mycoplasma compared to conventional enzyme immunoassays. Eur J Clin Microbiol Infect Dis. 2004;23:412–4.
    1. Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.
    1. Waris ME, Toikka P, Saarinen T, et al. Diagnosis of Mycoplasma pneumoniae pneumonia in children. J Clin Microbiol. 1998;36:3155–9.
    1. Bernet C, Garret M, de Barbeyrac B, et al. Detection of Mycoplasma pneumoniae by using the polymerase chain reaction. J Clin Microbiol. 1989;27:2492–6.
    1. Hardegger D, Nadal D, Bossart W, et al. Rapid detection of Mycoplasma pneumoniae in clinical samples by real-time PCR. J Microbiol Methods. 2000;41:45–51.
    1. Jensen JS, Sondergard-Andersen J, Uldum SA, et al. Detection of Mycoplasma pneumoniae in simulated clinical samples by polymerase chain reaction. Brief report. APMIS. 1989;97:1046–8.
    1. Luneberg E, Jensen JS, Frosch M. Detection of Mycoplasma pneumoniae by polymerase chain reaction and nonradioactive hybridization in microtiter plates. J Clin Microbiol. 1993;31:1088–94.
    1. Nadala D, Bossart W, Zucol F, et al. Community-acquired pneumonia in children due to Mycoplasma pneumoniae: diagnostic performance of a seminested 16S rDNA-PCR. Diagn Microbiol Infect Dis. 2001;39:15–9.
    1. Dowell SF, Peeling RW, Boman J, et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada) Clin Infect Dis. 2001;33:492–503.
    1. Copelovitch L, Kaplan BS. Streptococcus pneumoniae–associated hemolytic uremic syndrome: classification and the emergence of serotype 19A. Pediatrics. 2010;125:e174–82.
    1. Waters AM, Kerecuk L, Luk D, et al. Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United Kingdom experience. J Pediatr. 2007;151:140–4.
    1. Brandt J, Wong C, Mihm S, et al. Invasive pneumococcal disease and hemolytic uremic syndrome. Pediatrics. 2002;110:371–6.
    1. Bender JM, Ampofo K, Byington CL, et al. Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children. Pediatr Infect Dis J. 2010;29:712–6.
    1. Korppi M, Heiskanen-Kosma T, Leinonen M. White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children. Eur Respir J. 1997;10:1125–9.
    1. Bachur R, Perry H, Harper MB. Occult pneumonias: empiric chest radiographs in febrile children with leukocytosis. Ann Emerg Med. 1999;33:166–73.
    1. Murphy CG, van de Pol AC, Harper MB, et al. Clinical predictors of occult pneumonia in the febrile child. Acad Emerg Med. 2007;14:243–9.
    1. Rutman MS, Bachur R, Harper MB. Radiographic pneumonia in young, highly febrile children with leukocytosis before and after universal conjugate pneumococcal vaccination. Pediatr Emerg Care. 2009;25:1–7.
    1. Nohynek H, Valkeila E, Leinonen M, et al. Erythrocyte sedimentation rate, white blood cell count and serum C-reactive protein in assessing etiologic diagnosis of acute lower respiratory infections in children. Pediatr Infect Dis J. 1995;14:484–90.
    1. Korppi M, Remes S. Serum procalcitonin in pneumococcal pneumonia in children. Eur Respir J. 2001;17:623–7.
    1. Korppi M, Remes S, Heiskanen-Kosma T. Serum procalcitonin concentrations in bacterial pneumonia in children: a negative result in primary healthcare settings. Pediatr Pulmonol. 2003;35:56–61.
    1. Toikka P, Irjala K, Juven T, et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J. 2000;19:598–602.
    1. Moulin F, Raymond J, Lorrot M, et al. Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child. 2001;84:332–6.
    1. Khan DA, Rahman A, Khan FA. Is procalcitonin better than C-reactive protein for early diagnosis of bacterial pneumonia in children? J Clin Lab Anal. 2010;24:1–5.
    1. Prat C, Dominguez J, Rodrigo C, et al. Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection. Pediatr Infect Dis J. 2003;22:963–8.
    1. Nascimento-Carvalho CM, Cardoso MR, Barral A, et al. Procalcitonin is useful in identifying bacteraemia among children with pneumonia. Scand J Infect Dis. 2010;42:644–9.
    1. Swingler GH, Zwarenstein M. Chest radiograph in acute respiratory infections. Cochrane Database Syst Rev. 2008;23 CD001268.
    1. Swingler GH, Hussey GD, Zwarenstein M. Randomised controlled trial of clinical outcome after chest radiograph in ambulatory acute lower-respiratory infection in children. Lancet. 1998;351:404–8.
    1. Novack V, Avnon LS, Smolyakov A, et al. Disagreement in the interpretation of chest radiographs among specialists and clinical outcomes of patients hospitalized with suspected pneumonia. Eur J Intern Med. 2006;17:43–7.
    1. Alario AJ, McCarthy PL, Markowitz R, et al. Usefulness of chest radiographs in children with acute lower respiratory tract disease. J Pediatr. 1987;111:187–93.
    1. Grossman LK, Caplan SE. Clinical, laboratory, and radiological information in the diagnosis of pneumonia in children. Ann Emerg Med. 1988;17:43–6.
    1. Bushyhead JB, Wood RW, Tompkins RK, et al. The effect of chest radiographs on the management and clinical course of patients with acute cough. Med Care. 1983;21:661–73.
    1. Mathews B, Shah S, Cleveland RH, et al. Clinical predictors of pneumonia among children with wheezing. Pediatrics. 2009;124:e29–36.
    1. Homier V, Bellavance C, Xhignesse M. Prevalence of pneumonia in children under 12 years of age who undergo abdominal radiography in the emergency department. CJEM. 2007;9:347–51.
    1. Bloomfield FH, Teele RL, Voss M, et al. Inter- and intra-observer variability in the assessment of atelectasis and consolidation in neonatal chest radiographs. Pediatr Radiol. 1999;29:459–62.
    1. Albaum MN, Hill LC, Murphy M, et al. Interobserver reliability of the chest radiograph in community-acquired pneumonia. PORT Investigators. Chest. 1996;110:343–50.
    1. Johnson J, Kline JA. Intraobserver and interobserver agreement of the interpretation of pediatric chest radiographs. Emerg Radiol. 2010;17:285–90.
    1. Hopstaken RM, Witbraad T, van Engelshoven JM, et al. Inter-observer variation in the interpretation of chest radiographs for pneumonia in community-acquired lower respiratory tract infections. Clin Radiol. 2004;59:743–52.
    1. Tudor GR, Finlay D, Taub N. An assessment of inter-observer agreement and accuracy when reporting plain radiographs. Clin Radiol. 1997;52:235–8.
    1. Stickler GB, Hoffman AD, Taylor WF. Problems in the clinical and roentgenographic diagnosis of pneumonia in young children. Clin Pediatr (Phila) 1984;23:398–9.
    1. Davies HD, Wang EE, Manson D, et al. Reliability of the chest radiograph in the diagnosis of lower respiratory infections in young children. Pediatr Infect Dis J. 1996;15:600–4.
    1. Young M, Marrie TJ. Interobserver variability in the interpretation of chest roentgenograms of patients with possible pneumonia. Arch Intern Med. 1994;154:2729–32.
    1. Cherian T, Mulholland EK, Carlin JB, et al. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ. 2005;83:353–9.
    1. Gatt ME, Spectre G, Paltiel O, et al. Chest radiographs in the emergency department: is the radiologist really necessary? Postgrad Med J. 2003;79:214–7.
    1. Gibson NA, Hollman AS, Paton JY. Value of radiological follow up of childhood pneumonia. BMJ. 1993;307:1117.
    1. Virkki R, Juven T, Mertsola J, et al. Radiographic follow-up of pneumonia in children. Pediatr Pulmonol. 2005;40:223–7.
    1. Grossman LK, Wald ER, Nair P, et al. Roentgenographic follow-up of acute pneumonia in children. Pediatrics. 1979;63:30–1.
    1. Wacogne I, Negrine RJ. Are follow up chest x ray examinations helpful in the management of children recovering from pneumonia? Arch Dis Child. 2003;88:457–8.
    1. Heaton P, Arthur K. The utility of chest radiography in the follow-up of pneumonia. N Z Med J. 1998;111:315–7.
    1. Bruns AH, Oosterheert JJ, Prokop M, et al. Patterns of resolution of chest radiograph abnormalities in adults hospitalized with severe community-acquired pneumonia. Clin Infect Dis. 2007;45:983–91.
    1. Fiorino EK, Panitch HB. Recurrent pneumonia. In: Shah SS, editor. Pediatric practice: infectious diseases. New York: McGraw-Hill Medical; 2009. pp. 321–31.
    1. Uyeki T. Diagnostic testing for 2009 pandemic influenza A (H1N1) virus infection in hospitalized patients. New Engl J Med. 2009;361:e114.
    1. Bar-Zohar D, Sivan Y. The yield of flexible fiberoptic bronchoscopy in pediatric intensive care patients. Chest. 2004;126:1353–9.
    1. Tang LF, Chen ZM. Fiberoptic bronchoscopy in neonatal and pediatric intensive care units: a 5-year experience. Med Princ Pract. 2009;18:305–9.
    1. Manali E, Papadopoulos A, Tsiodras S, et al. The impact on community acquired pneumonia empirical therapy of diagnostic bronchoscopic techniques. Scand J Infect Dis. 2008;40:286–92.
    1. Fagon JY, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med. 2000;132:621–30.
    1. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165:867–903.
    1. Gauvin F, Lacroix J, Guertin MC, et al. Reproducibility of blind protected bronchoalveolar lavage in mechanically ventilated children. Am J Respir Crit Care Med. 2002;165:1618–23.
    1. Labenne M, Poyart C, Rambaud C, et al. Blind protected specimen brush and bronchoalveolar lavage in ventilated children. Crit Care Med. 1999;27:2537–43.
    1. Vuori-Holopainen E, Salo E, Saxen H, et al. Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods. Clin Infect Dis. 2002;34:583–90.
    1. Manhire A, Charig M, Clelland C, et al. Guidelines for radiologically guided lung biopsy. Thorax. 2003;58:920–36.
    1. Kornecki A, Shemie SD. Open lung biopsy in children with respiratory failure. Crit Care Med. 2001;29:1247–50.
    1. Acosta EP, Kimberlin DW. Determination of appropriate dosing of influenza drugs in pediatric patients. Clin Pharmacol Ther. 2010
    1. American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement: recommendations for prevention and control of influenza in children, 2010–2011. Pediatrics. 2010;126:816–26.
    1. Klein JO. Bacterial pneumonias. In: Cherry J, Kaplan S, Demmler-Harrison G, editors. Feigin & Cherry's textbook of pediatric infectious diseases. 6th ed. Vol 1. Philadelphia, PA: Saunders/Elsevier; 2009. pp. 302–14.
    1. Weinstein MP, Klugman KP, Jones RN. Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance. Clin Infect Dis. 2009;48:1596–600.
    1. Dagan R, Hoberman A, Johnson C, et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J. 2001;20:829–37.
    1. Hazir T, Qazi SA, Bin Nisar Y, et al. Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2–59 months: a multi-centre, double blind, randomised controlled trial in Pakistan. Arch Dis Child. 2007;92:291–7.
    1. Bradley JS, Garonzik SM, Forrest A, et al. Pharmacokinetics, pharmacodynamics, and Monte Carlo simulation: selecting the best antimicrobial dose to treat an infection. Pediatr Infect Dis J. 2010;29:1043–6.
    1. Bradley JS, Garonzik SM, Forrest A, et al. Pharmacokinetics, pharmacodynamics, and Monte Carlo simulation: selecting the best antimicrobial dose to treat an infection. Pediatr Infect Dis J. 2010;29:1043–46.
    1. Kyaw MH, Lynfield R, Schaffner W, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med. 2006;354:1455–63.
    1. Harrison CJ, Woods C, Stout G, et al. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. J Antimicrob Chemother. 2009;63:511–9.
    1. Morita JY, Kahn E, Thompson T, et al. Impact of azithromycin on oropharyngeal carriage of group A Streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus pneumoniae. Pediatr Infect Dis J. 2000;19:41–6.
    1. Sader HS, Jacobs MR, Fritsche TR. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate. Diagn Microbiol Infect Dis. 2007;57:5S–12S.
    1. Pallares R, Capdevila O, Linares J, et al. The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections. Am J Med. 2002;113:120–6.
    1. Roson B, Carratala J, Tubau F, et al. Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone. Microb Drug Resist. 2001;7:85–96.
    1. Chumpa A, Bachur RG, Harper MB. Bacteremia-associated pneumococcal pneumonia and the benefit of initial parenteral antimicrobial therapy. Pediatr Infect Dis J. 1999;18:1081–5.
    1. Lappin E, Ferguson AJ. Gram-positive toxic shock syndromes. Lancet Infect Dis. 2009;9:281–90.
    1. Forrest GN, Tamura K. Rifampin combination therapy for nonmycobacterial infections. Clin Microbiol Rev. 2010;23:14–34.
    1. Como-Sabetti K, Harriman KH, Buck JM, et al. Community-associated methicillin-resistant Staphylococcus aureus: trends in case and isolate characteristics from six years of prospective surveillance. Public Health Rep. 2009;124:427–35.
    1. Miller LG, Kaplan SL. Staphylococcus aureus: a community pathogen. Infect Dis Clin North Am. 2009;23:35–52.
    1. Mulholland S, Gavranich JB, Chang AB. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst Rev. 2010;7 CD004875.
    1. Matsubara K, Morozumi M, Okada T, et al. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. J Infect Chemother. 2009;15:380–3.
    1. Kingston JR, Chanock RM, Mufson MA, et al. Eaton agent pneumonia. JAMA. 1961;176:118–23.
    1. Rasch JR, Mogabgab WJ. Therapeutic effect of erythromycin on Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother (Bethesda) 1965;5:693–9.
    1. Plouffe JF. Importance of atypical pathogens of community-acquired pneumonia. Clin Infect Dis. 2000;31(Suppl 2):S35–9.
    1. Bradley JS, Arguedas A, Blumer JL, et al. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia. Pediatr Infect Dis J. 2007;26:868–78.
    1. Burillo A, Bouza E. Chlamydophila pneumoniae. Infect Dis Clin North Am. 2010;24:61–71.
    1. Hammerschlag MR. Pneumonia due to Chlamydia pneumoniae in children: epidemiology, diagnosis, and treatment. Pediatr Pulmonol. 2003;36:384–90.
    1. Heinonen S, Silvennoinen H, Lehtinen P, et al. Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial. Clin Infect Dis. 2010;51:887–94.
    1. McGeer A, Green KA, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis. 2007;45:1568–75.
    1. Siston AM, Rasmussen SA, Honein MA, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA. 2010;303:1517–25.
    1. Farias JA, Fernandez A, Monteverde E, et al. Critically ill infants and children with influenza A (H1N1) in pediatric intensive care units in Argentina. Intensive Care Med. 2010;36:1015–22.
    1. Lee N, Choi KW, Chan PK, et al. Outcomes of adults hospitalised with severe influenza. Thorax. 2010;65:510–5.
    1. Wildschut ED, de Hoog M, Ahsman MJ, et al. Plasma concentrations of oseltamivir and oseltamivir carboxylate in critically ill children on extracorporeal membrane oxygenation support. PLoS One. 2010;5:e10938.
    1. Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children: diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1003–32.
    1. Committee on Infectious Diseases. From the American Academy of Pediatrics: policy statements—modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics. 2009;124:1694–701.
    1. Carbonell-Estrany X, Simoes EA, Dagan R, et al. Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial. Pediatrics. 2010;125:e35–51.
    1. Patel SJ, Larson EL, Kubin CJ, et al. A review of antimicrobial control strategies in hospitalized and ambulatory pediatric populations. Pediatr Infect Dis J. 2007;26:531–7.
    1. Haider BA, Saeed MA, Bhutta ZA. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev. 2008;16 CD005976.
    1. Tice AD, Rehm SJ, Dalovisio JR, et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis. 2004;38:1651–72.
    1. Bradley JS, Ching DK, Hart CL. Invasive bacterial disease in childhood: efficacy of oral antibiotic therapy following short course parenteral therapy in non-central nervous system infections. Pediatr Infect Dis J. 1987;6:821–5.
    1. Blaschke AJ, Heyrend C, Byington CL, et al. Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J. 2011;30:289–94.
    1. Spellberg B, Talbot GH, Brass EP, et al. Position paper: recommended design features of future clinical trials of antibacterial agents for community-acquired pneumonia. Clin Infect Dis. 2008;47(Suppl 3):S249–65.
    1. Bradley JS, McCracken GH. Unique considerations in the evaluation of antibacterials in clinical trials for pediatric community-acquired pneumonia. Clin Infect Dis. 2008;47(Suppl 3):S241–8.
    1. Hasley PB, Albaum MN, Li YH, et al. Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? Arch Intern Med. 1996;156:2206–12.
    1. Senstad AC, Suren P, Brauteset L, et al. Community-acquired pneumonia (CAP) in children in Oslo, Norway. Acta Paediatr. 2009;98:332–6.
    1. Clark JE, Hammal D, Spencer D, et al. Children with pneumonia: how do they present and how are they managed? Arch Dis Child. 2007;92:394–8.
    1. Bueno Campana M, Agundez Reigosa B, Jimeno Ruiz S, et al. Is the incidence of parapneumonic pleural effusion increasing? Pediatr (Barc) 2008;68:92–8.
    1. Weigl JA, Puppe W, Belke O, et al. Population-based incidence of severe pneumonia in children in Kiel, Germany. Klin Padiatr. 2005;217:211–9.
    1. Fine NL, Smith LR, Sheedy PF. Frequency of pleural effusions in mycoplasma and viral pneumonias. N Engl J Med. 1970;283:790–3.
    1. Light RW. Pleural diseases. Dis Mon. 1992;38:261–331.
    1. Byington CL, Korgenski K, Daly J, et al. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J. 2006;25:250–4.
    1. Byington CL, Samore MH, Stoddard GJ, et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis. 2005;41:21–9.
    1. Hendrickson DJ, Blumberg DA, Joad JP, et al. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2008;27:1030–2.
    1. Lahti E, Peltola V, Virkki R, et al. Development of parapneumonic empyema in children. Acta Paediatr. 2007;96:1686–92.
    1. Chan W, Keyser-Gauvin E, Davis GM, et al. Empyema thoracis in children: a 26-year review of the Montreal Children's Hospital experience. J Pediatr Surg. 1997;32:870–2.
    1. Balfour-Lynn IM, Abrahamson E, Cohen G, et al. BTS guidelines for the management of pleural infection in children. Thorax. 2005;60(Suppl 1):i1–21.
    1. Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc. 2006;3:75–80.
    1. Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest. 2000;118:1158–71.
    1. Prais D, Kuzmenko E, Amir J, et al. Association of hypoalbuminemia with the presence and size of pleural effusion in children with pneumonia. Pediatrics. 2008;121:e533–8.
    1. Carter E, Waldhausen J, Zhang W, et al. Management of children with empyema: pleural drainage is not always necessary. Pediatr Pulmonol. 2010;45:475–80.
    1. Ferguson AD, Prescott RJ, Selkon JB, et al. The clinical course and management of thoracic empyema. QJM. 1996;89:285–9.
    1. Ramnath RR, Heller RM, Ben-Ami T, et al. Implications of early sonographic evaluation of parapneumonic effusions in children with pneumonia. Pediatrics. 1998;101:68–71.
    1. Himelman RB, Callen PW. The prognostic value of loculations in parapneumonic pleural effusions. Chest. 1986;90:852–6.
    1. Casado Flores J, Nieto Moro M, Berron S, et al. Usefulness of pneumococcal antigen detection in pleural effusion for the rapid diagnosis of infection by Streptococcus pneumoniae. Eur J Pediatr. 2009
    1. Obando I, Munoz-Almagro C, Arroyo LA, et al. Pediatric parapneumonic empyema, Spain. Emerg Infect Dis. 2008;14:1390–7.
    1. Goldbart AD, Leibovitz E, Porat N, et al. Complicated community acquired pneumonia in children prior to the introduction of the pneumococcal conjugated vaccine. Scand J Infect Dis. 2009;41:182–7.
    1. Kunyoshi V, Cataneo DC, Cataneo AJ. Complicated pneumonias with empyema and/or pneumatocele in children. Pediatr Surg Int. 2006;22:186–90.
    1. Schultz KD, Fan LL, Pinsky J, et al. The changing face of pleural empyemas in children: epidemiology and management. Pediatrics. 2004;113:1735–40.
    1. Hernandez-Bou S, Garcia-Garcia JJ, Esteva C, et al. Pediatric parapneumonic pleural effusion: epidemiology, clinical characteristics, and microbiological diagnosis. Pediatr Pulmonol. 2009;44:1192–200.
    1. Ani A, Okpe S, Akambi M, et al. Comparison of a DNA based PCR method with conventional methods for the detection of M. tuberculosis in Jos, Nigeria. J Infect Dev Ctries. 2009;3:470–5.
    1. Le Monnier A, Carbonnelle E, Zahar JR, et al. Microbiological diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids. Clin Infect Dis. 2006;42:1135–40.
    1. Ploton C, Freydiere AM, Benito Y, et al. Streptococcus pneumoniae thoracic empyema in children: rapid diagnosis by using the Binax NOW immunochromatographic membrane test in pleural fluids. Pathol Biol (Paris) 2006;54:498–501.
    1. Tarrago D, Fenoll A, Sanchez-Tatay D, et al. Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR. Clin Microbiol Infect. 2008;14:828–34.
    1. Ampofo K, Herbener A, Blaschke AJ, et al. Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah. Pediatr Infect Dis J. 2010;29:905–9.
    1. Lahti E, Mertsola J, Kontiokari T, et al. Pneumolysin polymerase chain reaction for diagnosis of pneumococcal pneumonia and empyema in children. Eur J Clin Microbiol Infect Dis. 2006;25:783–9.
    1. Heffner JE, Brown LK, Barbieri C, et al. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am J Respir Crit Care Med. 1995;151:1700–8.
    1. Mitri RK, Brown SD, Zurakowski D, et al. Outcomes of primary image-guided drainage of parapneumonic effusions in children. Pediatrics. 2002;110:e37.
    1. Picard E, Joseph L, Goldberg S, et al. Predictive factors of morbidity in childhood parapneumonic effusion-associated pneumonia: a retrospective study. Pediatr Infect Dis J. 2010;29:840–3.
    1. Burgess LJ, Maritz FJ, Le Roux I, et al. Combined use of pleural adenosine deaminase with lymphocyte/neutrophil ratio. Increased specificity for the diagnosis of tuberculous pleuritis. Chest. 1996;109:414–9.
    1. Chiu CY, Wu JH, Wong KS. Clinical spectrum of tuberculous pleural effusion in children. Pediatr Int. 2007;49:359–62.
    1. Hawkins JA, Scaife ES, Hillman ND, et al. Current treatment of pediatric empyema. Semin Thorac Cardiovasc Surg. 2004;16:196–200.
    1. Sonnappa S, Cohen G, Owens CM, et al. Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med. 2006;174:221–7.
    1. Grewal H, Jackson RJ, Wagner CW, et al. Early video-assisted thoracic surgery in the management of empyema. Pediatrics. 1999;103:e63.
    1. Kokoska ER, Chen MK. Position paper on video-assisted thoracoscopic surgery as treatment of pediatric empyema. J Pediatr Surg. 2009;44:289–93.
    1. Shah SS, DiCristina CM, Bell LM, et al. Primary early thoracoscopy and reduction in length of hospital stay and additional procedures among children with complicated pneumonia: results of a multicenter retrospective cohort study. Arch Pediatr Adolesc Med. 2008;162:675–81.
    1. Kurt BA, Winterhalter KM, Connors RH, et al. Therapy of parapneumonic effusions in children: video-assisted thoracoscopic surgery versus conventional thoracostomy drainage. Pediatrics. 2006;118:e547–53.
    1. Menendez R, Torres A. Treatment failure in community-acquired pneumonia. Chest. 2007;132:1348–55.
    1. Genne D, Kaiser L, Kinge TN, et al. Community-acquired pneumonia: causes of treatment failure in patients enrolled in clinical trials. Clin Microbiol Infect. 2003;9:949–54.
    1. Casado Flores J, Nieto Moro M, Berron S, et al. Usefulness of pneumococcal antigen detection in pleural effusion for the rapid diagnosis of infection by Streptococcus pneumoniae. Eur J Pediatr. 2010;169:581–4.
    1. Deresinski S. Vancomycin heteroresistance and methicillin-resistant Staphylococcus aureus. J Infect Dis. 2009;199:605–9.
    1. Centers for Disease Control and Prevention. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)—United States, May–August 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1071–4.
    1. Ampofo K, Bender J, Sheng X, et al. Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics. 2008;122:229–37.
    1. Jansen AG, Sanders EA, van der Ende A, et al. Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncytial virus activity? Epidemiol Infect. 2008;136:1448–54.
    1. Duttweiler L, Nadal D, Frey B. Pulmonary and systemic bacterial co-infections in severe RSV bronchiolitis. Arch Dis Child. 2004;89:1155–7.
    1. Randolph AG, Reder L, Englund JA. Risk of bacterial infection in previously healthy respiratory syncytial virus-infected young children admitted to the intensive care unit. Pediatr Infect Dis J. 2004;23:990–4.
    1. Kneyber MC, Blusse van Oud-Alblas H, van Vliet M, et al. Concurrent bacterial infection and prolonged mechanical ventilation in infants with respiratory syncytial virus lower respiratory tract disease. Intensive Care Med. 2005;31:680–5.
    1. Thorburn K, Harigopal S, Reddy V, et al. High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax. 2006;61:611–5.
    1. Chidi CC, Mendelsohn HJ. Lung abscess. A study of the results of treatment based on 90 consecutive cases. J Thorac Cardiovasc Surg. 1974;68:168–72.
    1. Estrera AS, Platt MR, Mills LJ, et al. Primary lung abscess. J Thorac Cardiovasc Surg. 1980;79:275–82.
    1. Ball WS, Jr., Bisset GS, 3rd, Towbin RB. Percutaneous drainage of chest abscesses in children. Radiology. 1989;171:431–4.
    1. Hoffer FA, Bloom DA, Colin AA, et al. Lung abscess versus necrotizing pneumonia: implications for interventional therapy. Pediatr Radiol. 1999;29:87–91.
    1. Lorenzo RL, Bradford BF, Black J, et al. Lung abscesses in children: diagnostic and therapeutic needle aspiration. Radiology. 1985;157:79–80.
    1. Patradoon-Ho P, Fitzgerald DA. Lung abscess in children. Paediatr Respir Rev. 2007;8:77–84.
    1. Halm EA, Fine MJ, Marrie TJ, et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA. 1998;279:1452–7.
    1. Wexler ID, Knoll S, Picard E, et al. Clinical characteristics and outcome of complicated pneumococcal pneumonia in a pediatric population. Pediatr Pulmonol. 2006;41:726–34.
    1. Lynch T, Platt R, Gouin S, et al. Can we predict which children with clinically suspected pneumonia will have the presence of focal infiltrates on chest radiographs? Pediatrics. 2004;113:e186–9.
    1. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics. 2006;118:1774–93.
    1. Mennella JA, Beauchamp GK. Optimizing oral medications for children. Clin Ther. 2008;30:2120–32.
    1. Cohen R, de La Rocque F, Lecuyer A, et al. Study of the acceptability of antibiotic syrups, suspensions, and oral solutions prescribed to pediatric outpatients. Eur J Pediatr. 2009;168:851–7.
    1. Ramgoolam A, Steele R. Formulations of antibiotics for children in primary care: effects on compliance and efficacy. Paediatr Drugs. 2002;4:323–33.
    1. Kobr J, Pizingerova K, Sasek L, et al. Treatment of encapsulated pleural effusions in children: a prospective trial. Pediatr Int. 2010;52:453–8.
    1. Bender BG, Bender SE. Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires. Immunol Allergy Clin North Am. 2005;25:107–30.
    1. Snodgrass SR, Vedanarayanan VV, Parker CC, et al. Pediatric patients with undetectable anticonvulsant blood levels: comparison with compliant patients. J Child Neurol. 2001;16:164–8.
    1. Bradley JS, Ching DK, Phillips SE. Outpatient therapy of serious pediatric infections with ceftriaxone. Pediatr Infect Dis J. 1988;7:160–4.
    1. Ruebner R, Keren R, Coffin S, et al. Complications of central venous catheters used for the treatment of acute hematogenous osteomyelitis. Pediatrics. 2006;117:1210–5.
    1. Peltola H, Unkila-Kallio L, Kallio MJ. Simplified treatment of acute staphylococcal osteomyelitis of childhood. The Finnish Study Group. Pediatrics. 1997;99:846–50.
    1. Zaoutis T, Localio AR, Leckerman K, et al. Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for acute osteomyelitis in children. Pediatrics. 2009;123:636–42.
    1. Watt JP, Wolfson LJ, O'Brien KL, et al. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet. 2009;374:903–11.
    1. O'Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893–902.
    1. World pneumonia day: November 2, 2009. MMWR. 2009;58:1184.
    1. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737–46.
    1. Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. 1993;269:221–6.
    1. Pilishvili T, Lexau C, Farley MM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201:32–41.
    1. Centers for Disease Control and Prevention. ACIP provisional recommendations for use of 13-valent pneumococcal conjugate vaccien (PCV13) among infants and children. Available at: . Accessed 14 August 2011.
    1. Bender JM, Ampofo K, Korgenski K, et al. Pneumococcal necrotizing pneumonia in Utah: does serotype matter? Clin Infect Dis. 2008;46:1346–52.
    1. Hortal M, Sehabiague G, Camou T, et al. Pneumococcal pneumonia in hospitalized Uruguayan children and potential prevention with different vaccine formulations. J Pediatr. 2008;152:850–3.
    1. Tan TQ, Mason EO, Jr., Wald ER, et al. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics. 2002;110:1–6.
    1. Langley JM, Kellner JD, Solomon N, et al. Empyema associated with community-acquired pneumonia: a Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study. BMC Infect Dis. 2008;8:129.
    1. Ramphul N, Eastham KM, Freeman R, et al. Cavitatory lung disease complicating empyema in children. Pediatr Pulmonol. 2006;41:750–3.
    1. Eastham KM, Freeman R, Kearns AM, et al. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax. 2004;59:522–5.
    1. Eltringham G, Kearns A, Freeman R, et al. Culture-negative childhood empyema is usually due to penicillin-sensitive Streptococcus pneumoniae capsular serotype 1. J Clin Microbiol. 2003;41:521–2.
    1. Neuzil KM, Mellen BG, Wright PF, et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342:225–31.
    1. Ampofo K, Gesteland PH, Bender J, et al. Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics. 2006;118:2409–17.
    1. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342:232–9.
    1. Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med. 2006;355:31–40.
    1. Joshi AY, Iyer VN, St Sauver JL, et al. Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: a case-control study. Vaccine. 2009;27:4457–61.
    1. Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med. 2007;356:685–96.
    1. O'Brien KL, Walters MI, Sellman J, et al. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis. 2000;30:784–9.
    1. Finelli L, Fiore A, Dhara R, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics. 2008 Oct. 122(4):805–11.
    1. Chien YW, Klugman KP, Morens DM. Bacterial pathogens and death during the 1918 influenza pandemic. N Engl J Med. 2009;361:2582–3.
    1. Klugman KP, Chien YW, Madhi SA. Pneumococcal pneumonia and influenza: a deadly combination. Vaccine. 2009;27(Suppl 3):C9–C14.
    1. Klugman KP, Astley CM, Lipsitch M. Time from illness onset to death, 1918 influenza and pneumococcal pneumonia. Emerg Infect Dis. 2009;15:346–7.
    1. Centers for Disease Control and Prevention. ACIP provisional recommendations for the use of influenza vaccines. 2010. Available at: . Accessed 14 August 2011.
    1. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360:588–98.
    1. Meissner HC, Bocchini JA, Jr, Brady MT, et al. The role of immunoprophylaxis in the reduction of disease attributable to respiratory syncytial virus. Pediatrics. 2009;124:1676–9.
    1. Dowell SF, Kupronis BA, Zell ER, et al. Mortality from pneumonia in children in the United States, 1939 through 1996. N Engl J Med. 2000;342:1399–407.
    1. Weiss AK, Hall M, Lee GE, et al. Adjunct corticosteroids in children hospitalized with community-acquired pneumonia. Pediatrics. 2011;127:e255–63.
    1. Gorton CP, Jones JL. Wide geographic variation between Pennsylvania counties in the population rates of hospital admissions for pneumonia among children with and without comorbid chronic conditions. Pediatrics. 2006;117:176–80.
    1. Lieu TA, Ray GT, Black SB, et al. Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. JAMA. 2000;283:1460–8.
    1. Paladino JA, Adelman MH, Schentag JJ, et al. Direct costs in patients hospitalised with community-acquired pneumonia after non-response to outpatient treatment with macrolide antibacterials in the US. Pharmacoeconomics. 2007;25:677–83.
    1. Shoham Y, Dagan R, Givon-Lavi N, et al. Community-acquired pneumonia in children: quantifying the burden on patients and their families including decrease in quality of life. Pediatrics. 2005;115:1213–9.
    1. Kohn GL, Walston C, Feldstein J, et al. Persistent abnormal lung function after childhood empyema. Am J Respir Med. 2002;1:441–5.
    1. McLaughlin FJ, Goldmann DA, Rosenbaum DM, et al. Empyema in children: clinical course and long-term follow-up. Pediatrics. 1984;73:587–93.
    1. Redding GJ, Walund L, Walund D, et al. Lung function in children following empyema. Am J Dis Child. 1990;144:1337–42.
    1. Satish B, Bunker M, Seddon P. Management of thoracic empyema in childhood: does the pleural thickening matter? Arch Dis Child. 2003;88:918–21.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir